PHRM and PHRRF Related Headlines
Go Back- PharmaTher receives FDA approval for ketamine product KETARx
- PharmaTher Announces FDA Approval of Ketamine (KETARx™)
- PharmaTher Applauds FDA's New Commissioner’s National Priority Voucher (CNPV) Program, Citing Potential to Accelerate its Ketamine Programs for Mental Health, Pain, and Neurological Disorders,
PHRM and PHRRF Related Press Releases
Go Back- PharmaTher Announces FDA Approval of Ketamine (KETARx™)
- PharmaTher Applauds FDA's New Commissioner’s National Priority Voucher (CNPV) Program, Citing Potential to Accelerate its Ketamine Programs for Mental Health, Pain, and Neurological Disorders,
